60 degrees pharmaceuticals expands options for malaria prevention with introduction of arakoda® (tafenoquine) 8-count bottle format

New 8-count bottles now available through major retail pharmacies arakoda® is the only weekly prophylactic therapy to provide protection against the blood and liver stages of malaria washington, june 04, 2025 (globe newswire) --   60 degrees pharmaceuticals, inc.  (nasdaq: sxtp; sxtpw) (“60 degrees” or the “company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the introduction of a new 8-count bottle format for arakoda® (tafenoquine). the 8-count bottle format may be suitable for use with patients who are making shorter trips to areas of the world where malaria is endemic.
SXTP Ratings Summary
SXTP Quant Ranking